1. Current updates on microRNAs as regulators of chemoresistance
    Metin Çalışkan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  2. MicroRNA-139 inhibits the proliferation and migration of osteosarcoma cells via targeting forkhead-box P2
    Chunan Zhong et al, 2017, Life Sciences CrossRef
  3. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer
    Wanli Yang et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
  4. Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential
    Dharambir Kashyap et al, 2018, Mol Diagn Ther CrossRef
  5. HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression
    Hui Wang et al, 2018, J. Cell. Biochem. CrossRef
  6. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Yiqun Huang et al, 2018, Cancer Biomark CrossRef
  7. Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway
    Lanfang Zhang et al, 2017, Mol Carcinog CrossRef
  8. The Network of Non-coding RNAs in Cancer Drug Resistance
    Fabio Corrà et al, 2018, Front. Oncol. CrossRef
  9. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.
    Hua Liu et al, 2018, J Exp Clin Cancer Res CrossRef
  10. LincRNA-p21 enhances the sensitivity of radiotherapy for gastric cancer by targeting the β-catenin signaling pathway
    Lijun Chen et al, 2018, J Cell Biochem CrossRef
  11. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells
    Mingqi Wang et al, 2019, Gene CrossRef
  12. ncRNAs associated with drug resistance and the therapy of digestive system neoplasms
    Wei Feng et al, 2019, J Cell Physiol CrossRef
  13. Overexpression of long noncoding RNA GAS5 suppresses tumorigenesis and development of gastric cancer by sponging miR-106a-5p through the Akt/mTOR pathway
    Shuaijun Dong et al, 2019, Biology Open CrossRef
  14. Effects of radon on miR-34a–induced apoptosis in human bronchial epithelial BEAS-2B cells
    Jing Wu et al, 2019, Journal of Toxicology and Environmental Health, Part A CrossRef
  15. Non-coding RNA in drug resistance of gastric cancer
    Ya-Jun Luo et al, 2019, WJGO CrossRef
  16. Decitabine and all-trans retinoic acid synergistically exhibit cytotoxicity against elderly AML patients via miR-34a/MYCN axis
    Yang Cao et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  17. Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
    Xin Liu et al, 2020, Front. Cell Dev. Biol. CrossRef
  18. The role of miR‐34 in cancer drug resistance
    Sanaz Naghizadeh et al, 2020, J Cell Physiol CrossRef
  19. MicroRNAs and Long Non-coding RNAs in c-Met-Regulated Cancers
    Hong Zhan et al, 2020, Front. Cell Dev. Biol. CrossRef
  20. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Ling Wei et al, 2020, Mol Cancer CrossRef

  21. A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer


    Jiehong Kong et al, 2020, OTT CrossRef
  22. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9
    Jing Wang et al, 2017, Oncotarget CrossRef
  23. Non-coding RNAs underlying chemoresistance in gastric cancer
    Arash Poursheikhani et al, 2020, Cell Oncol. CrossRef
  24. microRNAs in gastric cancer: biomarkers and therapeutic targets
    Soudeh Ghafouri-Fard et al, 2020, Gene CrossRef
  25. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review)
    Chao Chen et al, 2019, Int J Oncol CrossRef

  26. MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?


    Haidar El Darsa et al, 2020, JEP CrossRef
  27. Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p
    Shunxiang Luo et al, 2020, Mol Med Rep CrossRef
  28. LINC00689 induces gastric cancer progression via modulating the miR‐338‐3p/HOXA3 axis
    Hui Lu et al, 2020, J Gene Med CrossRef
  29. A COMPARISON BETWEEN THE EFFECTS OF OVER-EXPRESSION OF miRNA-16 AND miRNA-34a ON CELL CYCLE PROGRESSION OF MESOTHELIOMA CELL LINES AND ON THEIR CISPLATIN SENSITIVITY
    S. Pinelli et al, 2020, Cancer Treatment and Research Communications CrossRef
  30. Blockage of ETS homologous factor inhibits the proliferation and invasion of gastric cancer cells through the c-Met pathway
    Meng-Li Gu et al, 2020, WJG CrossRef
  31. The comprehensive landscape of miR-34a in cancer research.
    Sijing Li et al, 2021, Cancer Metastasis Rev CrossRef
  32. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
    Amir Sadra Zangouei et al, 2021, Genes and Environ CrossRef
  33. Betaine downregulates microRNA 34a expression via a p53‐dependent manner in cisplatin‐induced nephrotoxicity in rats
    Rasha M. Hussein et al, 2021, J Biochem Mol Toxicol CrossRef
  34. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers
    Fatemeh Dashti et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
  35. The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer
    Yanping Yue et al, 2021, Front. Cell Dev. Biol. CrossRef
  36. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer
    Yiwen Wu et al, 2022, CCHTS CrossRef
  37. Mechanism of cisplatin resistance in gastric cancer and associated microRNAs.
    Changqing Liu et al, 2023, Cancer Chemother Pharmacol CrossRef
  38. MicroRNA-34 and gastrointestinal cancers: a player with big functions
    Wei Gao et al, 2024, Cancer Cell Int CrossRef
  39. The role of microRNAs in the gastric cancer tumor microenvironment
    Xianzhe Yu et al, 2024, Mol Cancer CrossRef